MediCeption Science

MediCeption Science is a global clinical and medical research organization with over a decade of experience serving pharmaceutical, biotechnology, and medical device companies. The company is CDSCO-approved and operates from offices in India with additional presence in Australia, Europe, Japan, Singapore, and the United States.

The organization provides end-to-end clinical trial support spanning Phase I-IV studies, post-marketing surveillance, real-world evidence generation, and epidemiological research. Core service lines include regulatory consulting, medical writing and publication support, health economics and outcomes research (HEOR), KOL engagement, and medico-marketing collaterals. The company reports completing over 20,000 projects for more than 100 clients, including top 50 global pharmaceutical companies.

MediCeption's leadership team combines clinical, regulatory, and operational expertise. The company emphasizes data-driven approaches to clinical research while supporting clients across multiple therapeutic areas including cardiology, endocrinology, critical care, oncology, and respiratory medicine.

Choose MediCeption when you need a clinical research partner with deep understanding of Indian regulatory requirements and Asia-Pacific market access. The organization's integrated service model allows pharmaceutical companies to consolidate clinical trials, regulatory submissions, medical writing, and KOL engagement activities under one vendor relationship.

Expect a medically-led approach with physicians in leadership roles and access to therapeutic area experts. The company's experience with major pharmaceutical clients suggests capability to handle complex, multi-phase clinical programs and regulatory documentation for both local and international submissions.

MediCeption operates exclusively in the healthcare sector as a CDSCO-approved clinical research organization. The company focuses on pharmaceutical and biotechnology industry clients, providing specialized services including clinical trial management, regulatory documentation for drug approvals, real-world evidence studies, and health economics research. Their healthcare vertical expertise spans cardiology, endocrinology, critical care, oncology, obstetrics and gynecology, diabetology, and respiratory medicine.

The organization's healthcare-specific capabilities include KOL profiling and engagement, advisory board management, continuing medical education programs, and medical information services designed specifically for pharmaceutical product lifecycle management and healthcare professional communication.

Pharmaceutical and biotechnology companies planning clinical trials in India or requiring CDSCO regulatory submissions. Companies seeking integrated clinical research, medical affairs, and market access services in Asia-Pacific markets. Organizations requiring real-world evidence generation, health economics research, or KOL engagement across therapeutic areas including cardiology, endocrinology, oncology, and metabolic diseases.